Biotricity (NASDAQ:BTCY – Get Free Report) is expected to be posting its quarterly earnings results on Tuesday, February 18th. Analysts expect Biotricity to post earnings of ($0.11) per share for the quarter.
Biotricity Price Performance
Shares of NASDAQ BTCY opened at $0.43 on Friday. Biotricity has a fifty-two week low of $0.19 and a fifty-two week high of $1.67. The company’s 50 day simple moving average is $0.35 and its 200 day simple moving average is $0.36. The firm has a market capitalization of $10.56 million, a P/E ratio of -0.31 and a beta of 1.18.
Analyst Upgrades and Downgrades
Separately, HC Wainwright restated a “neutral” rating on shares of Biotricity in a research report on Monday, November 18th.
About Biotricity
Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.
Read More
- Five stocks we like better than Biotricity
- How to trade using analyst ratings
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- Most active stocks: Dollar volume vs share volume
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- Manufacturing Stocks Investing
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with MarketBeat.com's FREE daily email newsletter.
